Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUL12101 Eye Drops in Moderate to Severe Dry Eye (Phase IIa)
CTR20243231Phase 2Active
- Sponsor
- The United Laboratories International Holdings
- Start
- Oct 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in dry eye syndrome (DED), sponsored by The United Laboratories International Holdings. Started Oct 2024; status: active.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20243231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243231.